All products / DC9969
CCT251921
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $750 USDRequest a quote / confirm availability → |
| 250 mg | $1,300 USDRequest a quote / confirm availability → |
| 1 g | $2,600 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
CCT251921 is a potent, selective, and orally bioavailable small-molecule modulators of the mediator complex-associated kinases CDK8 and CDK19. (IC50 data: CDK8:=2.3 nM; CDK19 = 2.6 nM). CCT251921 showed the optimal compromise of in vitro biochemical, pharmacokinetic, and physicochemical properties and is suitable for progression to animal models of cancer. The Mediator complex-associated cyclin-dependent kinase CDK8 has been implicated in human disease, particularly in colorectal cancer where it has been reported as a putative oncogene.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC9969 |
|---|---|
| Product name | CCT251921 |
| CAS | 1607837-31-9 |
| Molecular formula | C21H23ClN6O |
| Molecular weight | 410.91 |
| Purity | >98% |
| SMILES | Cn1ncc2cc(-c3cnc(N)c(Cl)c3N3CCC4(CCNC4=O)CC3)ccc21 |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — CCT251921 (DC9969)